Dtsch Med Wochenschr 2011; 136(42): 2158-2164
DOI: 10.1055/s-0031-1292028
Übersicht | Review article
Angiologie
© Georg Thieme Verlag KG Stuttgart · New York

Mechanische Komplikationen vollimplantierbarer venöser Portsysteme

Mechanical complications of venous access portsA. Surov1 , C. Behrmann1 , E. Fiedler2
  • 1Klinik und Poliklinik für Diagnostische Radiologie, Martin-Luther-Universität Halle-Wittenberg
  • 2Klinik und Poliklinik für Dermatologie und Venerologie, Martin-Luther-Universität Halle-Wittenberg
Further Information

Publication History

eingereicht: 14.3.2011

akzeptiert: 9.6.2011

Publication Date:
11 October 2011 (online)

Literatur

  • 1 Aitken D R, Minton J P. The „pinch-off sign“: a warning of impending problems with permanent subclavian catheters.  Am J Surg. 1984;  148 633-636
  • 2 Akl E A, Kamath G, Yosuico V. et al . Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis.  Cancer. 2008;  112 2483-2492
  • 3 Andris D A, Krzywda E A, Schulte W, Ausman R, Quebbeman E J. Pinch-off syndrome: a rare etiology for central venous catheter occlusion.  JPEN J Parenter Enteral Nutr. 1994;  18 531-533
  • 4 Ballarini C, Intra M, Pisani Ceretti A. et al . Complications of subcutaneous infusion port in the general oncology population.  Oncology. 1999;  56 97-102
  • 5 Barrios C H, Zuke J E, Blaes B, Hirsch J D, Lyss A P. Evaluation of an implantable venous access system in a general oncology population.  Oncology. 1992;  49 474-478
  • 6 Behrend M, Paboura E, Raab R. Late embolization of an unfractured port catheter into the heart: report of a case.  Surg Today. 2002;  32 724-726
  • 7 Biagi E, Arrigo C, Dell’Orto M G. et al . Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies.  Support Care Cancer. 1997;  5 228-233
  • 8 Biffi R, de Braud F, Orsi F. et al . Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.  Ann Oncol. 1998;  9 767-773
  • 9 Biffi R, Pozzi S, Agazzi A. et al . Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.  Ann Oncol. 2004;  15 296-300
  • 10 Bodner L J, Nosher J L, Patel K M. et al . Peripheral venous access ports: outcomes analysis in 109 patients.  Cardiovasc Intervent Radiol. 2000;  23 187-193
  • 11 Brown D F, Muirhead M J, Travis P M, Vire S R, Weller J, Hauer-Jensen M. Mode of chemotherapy does not affect complications with an implantable venous access device.  Cancer. 1997;  80 966-972
  • 12 Cil B E, Canyigit M, Peynircioglu B. et al . Subcutaneous venous port implantation in adult patients: a single center experience.  Diagn Interv Radiol. 2006;  12 93-98
  • 13 Cohn D E, Mutch D G, Rader J S, Farrell M, Awantang R, Herzog T J. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.  Gynecol Oncol. 2001;  83 533-536
  • 14 Dahl H D, Hengstmann J H, Bode U, Hansen H. Klinische Anwendung eines vollständig implantierbaren Kathetersystems.  Dtsch Med Wochenschr. 1986;  111 88-92
  • 15 de Gregorio M A, Miguelena J M, Fernandez J A, de Gregorio C, Tres A, Alfonso E R. Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients.  Eur Radiol. 1996;  6 748-752
  • 16 Eastridge B J, Lefor A T. Complications of indwelling venous access devices in cancer patients.  J Clin Oncol. 1995;  13 233-238
  • 17 Herrmann K A, Waggershauser T, Helmberger T, Heinemann V, Sittek H, Reiser M. Interventionell-radiologische perkutane Implantation intravenoser Port-Katheter-Systeme.  Radiologe. 1999;  39 777-782
  • 18 Ingle R J. Rare complications of vascular access devices.  Semin Oncol Nurs. 1995;  11 184-193
  • 19 Kluge A, Stroh H, Wagner D, Rauber K. Durchleuchtungsgesteuerte Implantation subkutaner Venenports: Komplikationen und Langzeitergebnisse.  Rofo. 1998;  169 63-67
  • 20 Kock H J, Pietsch M, Krause U, Wilke H, Eigler F W. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems.  World J Surg. 1998;  22 12-16
  • 21 Koller M, Papa M Z, Zweig A, Ben-Ari G. Spontaneous leak and transection of permanent subclavian catheters.  J Surg Oncol. 1998;  68 166-168
  • 22 Koonings P P, Given F T Jr. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.  J Am Coll Surg. 1994;  178 164-166
  • 23 Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury.  Lancet Oncol. 2002;  3 684-692
  • 24 Lehr L, Brandmair W, Kovacs J, von Sommoggy S. Erfahrungen mit 3151 zentralen Venenkathetern an einer Chirurgischen Klinik.  Dtsch Med Wochenschr. 1988;  113 1218-1223
  • 25 Lemmers N W, Gels M E, Sleijfer D T. et al . Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.  J Clin Oncol. 1996;  14 2916-2922
  • 26 Lersch C, Eckel F, Sader R. et al . Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy.  Oncology. 1999;  57 269-275
  • 27 Liu J C, Tseng H S, Chen C Y, Chern M S, Chang C Y. Percutaneous retrieval of 20 centrally dislodged Port-A catheter fragments.  Clin Imaging. 2004;  28 223-229
  • 28 Lokich J J, Bothe A Jr, Benotti P, Moore C. Complications and management of implanted venous access catheters.  J Clin Oncol. 1985;  3 710-717
  • 29 Lorch H, Zwaan M, Kagel C, Weiss H D. Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.  Cardiovasc Intervent Radiol. 2001;  24 180-184
  • 30 Lorenz M, Hottenrott C, Seufert R M, Encke A. Total implantierbarer dauerhafter zentralvenoser Zugang, Langzeiterfahrung mit subcutanen Infusionskammern.  Langenbecks Arch Chir. 1988;  373 302-309
  • 31 Ludwig R, Ludwig C U, Laffer U, Stoll H R, Obrecht J P. Vollständig subkutan implantierbares venöses Kathetersystem. Vier Jahre Erfahrung bei onkologischen Patienten.  Schweiz Med Wochenschr. 1988;  118 305-308
  • 32 Meranze S G, Burke D R, Feurer I D, Mullen J L. Spontaneous retraction of indwelling catheters: previously unreported complications.  JPEN J Parenter Enteral Nutr. 1988;  12 310-312
  • 33 Monreal M, Alastrue A, Rull M. et al . Upper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (Fragmin).  Thromb Haemost. 1996;  75 251-253
  • 34 Muhm M, Sunder-Plassmann G, Kuhrer I, Mullner M, Kalhs P, Druml W. Secondary migration: a complication of Hickman central venous catheters.  Bone Marrow Transplant. 1996;  18 651-654
  • 35 Myint H, McGregor J, Edwards R, Lucie N P. Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath).  Int J Artif Organs. 1994;  17 505-507
  • 36 Noyen J, Hoorntje J, de Langen Z, Leemslag J W, Sleijfer D. Spontaneous fracture of the catheter of a totally implantable venous access port: case report of a rare complication.  J Clin Oncol. 1987;  5 1295-1299
  • 37 Prager D, Hertzberg R W. Spontaneous intravenous catheter fracture and embolization from an implanted venous access port and analysis by scanning electron microscopy.  Cancer. 1987;  60 270-273
  • 38 Raad I I, Luna M, Khalil S A, Costerton J W, Lam C, Bodey G P. The relationship between the thrombotic and infectious complications of central venous catheters.  JAMA. 1994;  271 1014-1016
  • 39 Rauthe G, Altmann C. Complications in connection with venous port systems: prevention and therapy.  Eur J Surg Oncol. 1998;  24 192-199
  • 40 Rodgers H C, Liddle K, Nixon S J, Innes J A, Greening A P. Totally implantable venous access devices in cystic fibrosis: complications and patients’ opinions.  Eur Respir J. 1998;  12 217-220
  • 41 Schwarz R E, Groeger J S, Coit D G. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.  Cancer. 1997;  79 1635-1640
  • 42 Starkhammar H, Bengtsson M, Morales O. Fibrin sleeve formation after long term brachial catheterisation with an implantable port device. A prospective venographic study.  Eur J Surg. 1992;  158 481-484
  • 43 Stein M, Wagner R H. Komplikationen zentralvenöser Portsysteme: Erfahrungsbericht über 2359 Implantationen.  Dtsch Med Wochenschr. 2005;  130 1129-1132
  • 44 Surov A, Buerke M, John E, Kosling S, Spielmann R P, Behrmann C. Intravenous port catheter embolization: mechanisms, clinical features, and management.  Angiology. 2008;  59 90-97
  • 45 Surov A, Jordan K, Buerke M. et al . Port catheter insufficiency: incidence and clinical-radiological correlations.  Onkologie. 2008;  31 455-461
  • 46 Teichgräber U K, Gebauer B, Benter T, Wagner J. Langfristige zentralvenöse Zugänge und deren Komplikationsmanagement.  Rofo. 2004;  176 944-952
  • 47 Teichgräber U K, Kausche S, Nagel S N, Gebauer B. Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.  Eur Radiol. 2011;  6 1224-1232
  • 48 Teichgräber U K, Pfitzmann R, Hofmann H A. Central venous port systems as an integral part of chemotherapy.  Dtsch Arztebl Int. 2011;  108 147-154
  • 49 Vicol C, Nollert G, Mair H, Reichart B. Port-a-Cath complicated by right atrial thrombus. Minimally invasive thrombectomy without cardiopulmonary bypass.  Z Kardiol. 2004;  93 706-708
  • 50 Winston C B, Wechsler R J, Kane M. Vertebral vein migration of a long-term central venous access catheter: a cause of brachial plexopathy.  J Thorac Imaging. 1994;  9 98-100
  • 51 Yip D, Funaki B. Subcutaneous chest ports via the internal jugular vein. A retrospective study of 117 oncology patients.  Acta Radiol. 2002;  43 371-375

Dr. med. Alexey Surov

Klinik für Diagnostische Radiologie
Martin-Luther-Universität Halle-Wittenberg

Ernst-Grube-Str. 40

06097 Halle

Email: alex.surow@medizin.uni-halle.de

    >